1. Chile Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Instituto de Diagnostico S.A.

Instituto de Diagnostico S.A.

2,595.30
USD
- -
- -
0.09EPS
Instituto de Diagnostico S.A.
BCS:INDISA1
(Santiago Stock Exchange)

Recent

price

2,595.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CLP
405.11
479.29
565.56
675.64
758.58
856.04
939.24
1,012.82
1,064.5
1,099.46
1,020.18
1,380.26
1,400.36
1,602.74
1,750.16
2,010.8
1,955.58
Revenue per Share
47.62
51.3
54.55
77.51
85.86
96.13
94.68
87.03
107.58
85.14
25.63
151.17
95.53
1.06
53.26
115.64
86.4
Basic EPS, GAAP
71.59
60.53
43.33
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
22.41
23.83
25.66
27.31
38.75
42.93
48.07
47.34
43.52
53.79
34.05
12.79
75.52
28.68
0.32
16.13
- -
Dividend per Share
241.34
257.44
283.68
322.43
366.94
415.24
461.56
505.1
556.98
599.69
620.97
696.68
744.52
761.49
799.1
1,433.44
1,546.3
Book Value per Share
241.34
257.44
283.68
321.67
365.15
412.55
458.85
499.87
549.35
595.27
613.93
674.31
700.62
700.26
733.78
1,430.72
1,541.94
Tangible Book Value per Share
137
137
137
137
137
137
137
137
137
137
137
137
137
137
137
135
147
Basic Weighted Avg Shares
55,341
65,475
77,260
92,299
103,628
116,942
128,308
138,351
145,411
150,185
139,356
188,543
191,288
218,934
239,071
272,306
286,929
Sales/Revenue/Turnover
16.43
15.6
14.86
15.77
15.35
14.74
13.06
12.16
11.99
10.43
3.84
11.91
6.77
1.92
6.13
4.62
5.18
Operating Margin (%)
2,265
2,598
3,073
- -
- -
- -
- -
594
737
1,194
1,123
1,052
1,039
1,077
919
9,403
9,434
Depreciation Expense
6,505
7,007
7,452
10,588
11,730
13,132
12,934
11,888
14,695
11,630
3,501
20,650
13,050
144
7,276
15,660
12,676
Net Income, GAAP
16.07
18.34
18.81
18.34
17.14
18.28
19.7
22.95
23.87
18.43
4.45
15.29
- -
- -
8.95
- -
- -
Effective Tax Rate (%)
11.75
10.7
9.65
11.47
11.32
11.23
10.08
8.59
10.11
7.74
2.51
10.95
6.82
0.07
3.04
5.75
4.42
Profit Margin (%)
3,274
4,566
10,222
10,169
10,761
14,832
24,137
20,923
23,888
22,247
12,494
-9,673
10,897
10,890
15,489
16,964
-2,387
Working Capital
- -
- -
34,529
31,716
29,599
37,005
49,936
47,211
45,950
41,811
38,863
39,672
80,827
82,507
79,651
76,865
73,563
LT Debt
33,001
35,201
38,785
44,078
50,159
56,725
63,053
68,996
76,083
81,918
84,825
95,166
101,701
104,020
109,156
207,270
223,589
Total Equity
18.98
24.15
12.69
13.2
14.04
14.87
12.12
10.69
10.82
9.9
3.69
11.87
- -
- -
6.31
- -
- -
Return on Invested Capital (%)
18.77
24.45
16.3
13.51
14.13
15.96
13.38
11.69
13.53
10.65
4.36
13.93
- -
- -
6.58
- -
- -
Return on Capital (%)
21.4
20.57
20.16
25.58
24.91
24.58
21.6
18.01
20.26
14.72
4.2
22.95
13.26
0.14
6.83
9.9
7.51
Return on Common Equity (%)

Capital Structure

CLP

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
23,117
26,493
51,153
LT Borrowings
69,495
67,076
64,708
LT Finance Leases
7,370
7,812
8,856
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
145
145
145
Market Capitalization
- -
- -
- -

Working Capital

CLP

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
111,939
108,428
118,064
Cash, Cash Equivalents & STI
17,658
16,013
12,334
Accounts Receivable, Net
65,845
63,443
70,482
Inventories
3,125
3,139
3,319
Total Current Liabilities
94,975
96,107
120,451
Payables & Accruals
- -
- -
- -
ST Debt
23,117
26,493
51,153
Deferred Revenue
- -
- -
- -

Growth Rates

CLP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.82%
23.23%
89.88%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
533.46%
1,082.27%
115.23%
Sales/Revenue/Turnover
9.3%
14.86%
13.9%
Total Cash Common Dividend
515.63%
1,033.41%
4,900.04%

Quarterly Revenue

CLP

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
55,139
61,491
60,600
61,841
239,071
2025
61,543
68,709
70,430
71,624
272,306
2026
70,080
74,795
- -
- -
- -

Quarterly Earnings Per Share

CLP

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4.36
20.24
14.38
13.48
53.26
2025
14.57
36.49
18.95
38.79
115.64
2026
1.66
25.94
- -
- -
- -

Quarterly Dividends Per Share

CLP

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.32
2025
- -
- -
- -
- -
16.13
2026
- -
- -
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Instituto de Diagnostico S.A. operates as a private healthcare service provider in Chile, managing and operating high-complexity medical facilities under the Clinica INDISA brand. The company provides a comprehensive range of inpatient, outpatient, and diagnostic healthcare services across multiple medical specialties. Its primary service portfolio comprises inpatient and critical care, including general adult and pediatric hospitalization, adult intensive care units (ICU), pediatric and neonatal intensive care units (NICU), intermediate treatment units (IMU), maternity and obstetric care, and complex surgical suites equipped with robotic-assisted surgery platforms such as the da Vinci Surgical System; emergency medical services, delivering 24/7 multidisciplinary urgent and trauma care for adult, pediatric, and obstetric patients; outpatient and ambulatory services, consisting of outpatient medical consultations across medical and surgical specialties, minor ambulatory surgery, vaccination centers, and physical and respiratory rehabilitation; diagnostic and clinical support services, including comprehensive clinical laboratory testing, molecular biology, anatomical pathology, blood banking, and advanced diagnostic imaging such as magnetic resonance imaging (MRI), spectral computed tomography (CT), positron emission tomography, mammography, ultrasound, endoscopy, and digital radiography; and digital healthcare solutions, encompassing telemedicine consultations, digital diagnostic results delivery, and patient care management through its integrated online platform. The company serves private health insurance (Isapre) affiliates, public health fund (Fonasa) beneficiaries under modality agreements, institutional clients, corporate health plans, and self-pay individuals primarily in the Santiago Metropolitan Region. In recent developments, Instituto de Diagnostico S.A. expanded its clinical capacity and regional reach through the full commissioning and operational scaling of Clinica INDISA Maipu, a major multi-specialty high-complexity hospital complex serving the southwestern district of Santiago; formed a consortium with EuroAmerica to acquire a 55.74% majority controlling interest in Clinica Las Condes S.A., significantly consolidating its market footprint in high-complexity tertiary healthcare; and divested its 11.69% minority equity stake in Hospital Clinico de Vina del Mar to Red Interclinica as part of its strategic capital allocation and core asset focus. Instituto de Diagnostico S.A. was founded in 1961 and is headquartered in Providencia, Santiago, Chile.